Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program.

Crandall JP, Mather K, Rajpathak SN, Goldberg RB, Watson K, Foo S, Ratner R, Barrett-Connor E, Temprosa M.

BMJ Open Diabetes Res Care. 2017 Oct 10;5(1):e000438. doi: 10.1136/bmjdrc-2017-000438. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Oct 25;5(1):e000438corr1.

2.

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome.

Sathyapalan T, Coady AM, Kilpatrick ES, Atkin SL.

Endocr Connect. 2017 Nov;6(8):811-816. doi: 10.1530/EC-17-0217. Epub 2017 Oct 10.

3.

Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress.

Urbano F, Bugliani M, Filippello A, Scamporrino A, Di Mauro S, Di Pino A, Scicali R, Noto D, Rabuazzo AM, Averna M, Marchetti P, Purrello F, Piro S.

Sci Rep. 2017 Sep 19;7(1):11863. doi: 10.1038/s41598-017-11070-x.

4.

The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature.

Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T.

Curr Cardiol Rev. 2017;13(3):209-216. doi: 10.2174/1573403X13666170426104611. Review.

PMID:
28462692
5.

Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.

Leibowitz M, Cohen-Stavi C, Basu S, Balicer RD.

Curr Cardiol Rep. 2017 Jun;19(6):52. doi: 10.1007/s11886-017-0858-6. Review.

6.

Effect of Atorvastatin on Glycaemic Parameters in Normoglycaemic and Prediabetic Subjects: A Prospective, Panel Study.

Parida S, Swain TR, Routray SN, Maiti R.

J Clin Diagn Res. 2017 Feb;11(2):FC04-FC09. doi: 10.7860/JCDR/2017/23741.9427. Epub 2017 Feb 1.

7.

Computational Drug Repositioning Using Continuous Self-Controlled Case Series.

Kuang Z, Thomson J, Caldwell M, Peissig P, Stewart R, Page D.

KDD. 2016 Aug;2016:491-500. doi: 10.1145/2939672.2939715.

8.

Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis.

Wang S, Cai R, Yuan Y, Varghese Z, Moorhead J, Ruan XZ.

Sci Rep. 2017 Jan 10;7:39982. doi: 10.1038/srep39982.

9.

Response to comment on: Statin use and risk of diabetes mellitus.

Chogtu B, Magazine R, Bairy KL.

World J Diabetes. 2016 Oct 15;7(18):481-482.

10.

Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database.

Lee J, Noh Y, Shin S, Lim HS, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S.

Ther Clin Risk Manag. 2016 Oct 11;12:1533-1543. eCollection 2016.

11.

Concomitant Medication Use and New-Onset Diabetes Among Medicaid Beneficiaries with Chronic Obstructive Pulmonary Disease.

Ajmera M, Shen C, Sambamoorthi U.

Popul Health Manag. 2017 Jun;20(3):224-232. doi: 10.1089/pop.2016.0047. Epub 2016 Sep 30.

PMID:
27689453
12.

Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.

Rahal AJ, ElMallah AI, Poushuju RJ, Itani R.

Saudi Med J. 2016 Oct;37(10):1051-60. doi: 10.15537/smj.2016.10.16078.

13.
14.

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.

Cholesterol Treatment Trialists' (CTT) Collaboration.

Am Heart J. 2016 Jun;176:63-9. doi: 10.1016/j.ahj.2016.01.016. Epub 2016 Jan 28.

15.

Effect of Serum Cholesterol on Insulin Secretory Capacity: Shimane CoHRE Study.

Wada M, Yano S, Hamano T, Nabika T, Kumakura S.

PLoS One. 2016 Feb 16;11(2):e0149452. doi: 10.1371/journal.pone.0149452. eCollection 2016.

16.

Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.

Ford I, Murray H, McCowan C, Packard CJ.

Circulation. 2016 Mar 15;133(11):1073-80. doi: 10.1161/CIRCULATIONAHA.115.019014. Epub 2016 Feb 10.

17.

Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients.

Castro MR, Simon G, Cha SS, Yawn BP, Melton LJ 3rd, Caraballo PJ.

J Gen Intern Med. 2016 May;31(5):502-8. doi: 10.1007/s11606-015-3583-0. Epub 2016 Feb 5.

18.

Evaluation of pleiotropic effects among common genetic loci identified for cardio-metabolic traits in a Korean population.

Kim YK, Hwang MY, Kim YJ, Moon S, Han S, Kim BJ.

Cardiovasc Diabetol. 2016 Feb 1;15:20. doi: 10.1186/s12933-016-0337-1.

19.

Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population.

Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K.

Int J Med Sci. 2016 Jan 1;13(1):25-38. doi: 10.7150/ijms.13800. eCollection 2016. Review.

20.

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia.

Parhofer KG.

Diabetes Metab J. 2015 Oct;39(5):353-62. doi: 10.4093/dmj.2015.39.5.353. Epub 2015 Oct 22. Review.

Supplemental Content

Support Center